Vitrolife Balance Sheet Health
Financial Health criteria checks 4/6
Vitrolife has a total shareholder equity of SEK13.1B and total debt of SEK1.9B, which brings its debt-to-equity ratio to 14.6%. Its total assets and total liabilities are SEK16.9B and SEK3.7B respectively. Vitrolife's EBIT is SEK772.0M making its interest coverage ratio 20.9. It has cash and short-term investments of SEK925.0M.
Key information
14.6%
Debt to equity ratio
SEK 1.92b
Debt
| Interest coverage ratio | 20.9x |
| Cash | SEK 925.00m |
| Equity | SEK 13.14b |
| Total liabilities | SEK 3.74b |
| Total assets | SEK 16.88b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VTRL.Y's short term assets (SEK2.1B) exceed its short term liabilities (SEK724.0M).
Long Term Liabilities: VTRL.Y's short term assets (SEK2.1B) do not cover its long term liabilities (SEK3.0B).
Debt to Equity History and Analysis
Debt Level: VTRL.Y's net debt to equity ratio (7.6%) is considered satisfactory.
Reducing Debt: VTRL.Y's debt to equity ratio has increased from 0% to 14.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable VTRL.Y has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: VTRL.Y is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 20.6% per year.